Sort By:
Featured

Migraine Relief and Motility

The purpose of this study is to measure gastrointestinal transit time in adult patients with migraines before and after initiation of CGRP medication. This study will be open label and you will either be given Emgality or Aimovig. You will use a wireless motility capsule (WMC) technology that tracks and records the speed of your stomach emptying. This will be done before and after the medication is administered.

View Trial Details
Ages 18 - 55
Study Topics Migraine

Intranasal Migraine Relief (One Year)

The purpose of this research study is to examine an investigational nasal spray for the treatment of an acute migraine headache. Rochester Clinical Research is currently enrolling individuals over the age of 18 years old who experience 2-8 migraines per month. The study drug is a CGRP receptor blocker administered through a nasal spray. The study will last approximately one year long with 17 visits to our office.

View Trial Details
Ages 18+
Study Topics Migraine

Intranasal Migraine Treatment

The purpose of this research study is to examine an investigational nasal spray for the treatment of one acute migraine headache. Rochester Clinical Research is currently enrolling individuals over the age of 18 years old who experience 2-8 migraines per month. The study drug is a CGRP receptor blocker administered through a nasal spray.

View Trial Details
Ages 18+
Study Topics Migraine